Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion type Assertion NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_head.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion description "[Our findings therefore argue that interference with MKK3 signaling through a novel treatment combination of p38 inhibitor plus temozolomide heightens the vulnerability of glioma to chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_provenance.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion evidence source_evidence_literature NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_provenance.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion SIO_000772 17406030 NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_provenance.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion wasDerivedFrom befree-20140225 NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_provenance.
- NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_assertion wasGeneratedBy ECO_0000203 NP380221.RAOf42tlhWJ5KYA4tFzpsoXED1LU5K7c9D1HsG-D2zJyw130_provenance.